U.S. Markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
119.92+1.32 (+1.11%)
At close: 4:00PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 529.87B
Enterprise Value 3N/A
Trailing P/E 167.25
Forward P/E 138.44
PEG Ratio (5 yr expected) 11.12
Price/Sales (ttm)14.79
Price/Book (mrq)19.90
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profit Margin 8.78%
Operating Margin (ttm)15.14%
Management Effectiveness
Return on Assets (ttm)7.03%
Return on Equity (ttm)14.41%
Income Statement
Revenue (ttm)2.02B
Revenue Per Share (ttm)8.23
Quarterly Revenue Growth (yoy)79.50%
Gross Profit (ttm)1.49B
EBITDA 356.32M
Net Income Avi to Common (ttm)176.93M
Diluted EPS (ttm)0.72
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)1.41B
Total Cash Per Share (mrq)5.66
Total Debt (mrq)548.4M
Total Debt/Equity (mrq)32.59
Current Ratio (mrq)3.82
Book Value Per Share (mrq)6.03
Cash Flow Statement
Operating Cash Flow (ttm)516.93M
Levered Free Cash Flow (ttm)394.13M

Trading Information

Stock Price History
Beta 2.03
52-Week Change 327.32%
S&P500 52-Week Change 315.17%
52 Week High 3121.96
52 Week Low 371.46
50-Day Moving Average 3116.59
200-Day Moving Average 394.23
Share Statistics
Avg Vol (3 month) 31.91M
Avg Vol (10 day) 31.63M
Shares Outstanding 5249.07M
Float 247.99M
% Held by Insiders 10.55%
% Held by Institutions 195.50%
Shares Short 35.01M
Short Ratio 33.45
Short % of Float 32.28%
Shares Short (prior month) 35.54M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Aug 24, 2000